PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?

SIMPLE SUMMARY: Despite the large use of inhibitors of Poly-ADP ribose polymerase (PARP-I), the feasibility and safety of their combination with radiotherapy (RT) are unclear. The combination may be particularly interesting in the oligometastatic setting in which patients may benefit from local RT d...

Descripción completa

Detalles Bibliográficos
Autores principales: Barcellini, Amelia, Loap, Pierre, Murata, Kazutoshi, Villa, Riccardo, Kirova, Youlia, Okonogi, Noriyuki, Orlandi, Ester
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582502/
https://www.ncbi.nlm.nih.gov/pubmed/34771545
http://dx.doi.org/10.3390/cancers13215380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582502/
https://www.ncbi.nlm.nih.gov/pubmed/34771545
http://dx.doi.org/10.3390/cancers13215380

Ejemplares similares